Propel Bio Management, LLC

Q3 2026 13F-HR Holdings

Location
Los Angeles, CA
Holdings as of
9/30/2026
Date filed
11/13/2026
Form type
13F-HR
Num holdings
30
Total value ($000)
$188,618
Net value change ($000)
-2,468 (-1.3%)
New positions
5
Sold out positions
4
Turnover %
14.9%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/13/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
COLL 8,950 NEW
ACHV 4,919 18.7%
CABA 3,935 NEW
MAZE 3,912 299.3%
PROK 3,336 NEW
AQST 2,609 43.5%
PAGP 2,074 6.7%
CRVS 1,994 189.7%
OBIO 1,708 44.1%
IRD 1,307 NEW
Top Reduces (Value $000, Stocks/ETFs)
ZVRA -3,636 -100.0%
PHAT -3,323 -29.2%
CORT -3,195 -26.9%
KYTX -3,105 -39.5%
IMMUNIC INC -2,794 -55.9%
EYPT -2,742 -100.0%
CLDX -2,641 -68.5%
PALI -2,394 -44.4%
SLN -2,105 -100.0%
ARTV -1,796 -26.6%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type